KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Deferred Taxes: 2009-2024

Historic Deferred Taxes for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $66.0 million.

  • Bausch Health Companies' Deferred Taxes fell 700.00% to -$24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.0 million, marking a year-over-year increase of 575.00%. This contributed to the annual value of $66.0 million for FY2024, which is 29.41% up from last year.
  • Latest data reveals that Bausch Health Companies reported Deferred Taxes of $66.0 million as of FY2024, which was up 29.41% from $51.0 million recorded in FY2023.
  • In the past 5 years, Bausch Health Companies' Deferred Taxes ranged from a high of $66.0 million in FY2024 and a low of -$475.0 million during FY2020.
  • Its 3-year average for Deferred Taxes is -$19.7 million, with a median of $51.0 million in 2023.
  • In the last 5 years, Bausch Health Companies' Deferred Taxes plummeted by 106.52% in 2020 and then spiked by 128.98% in 2023.
  • Bausch Health Companies' Deferred Taxes (Yearly) stood at -$475.0 million in 2020, then spiked by 52.63% to -$225.0 million in 2021, then climbed by 21.78% to -$176.0 million in 2022, then spiked by 128.98% to $51.0 million in 2023, then climbed by 29.41% to $66.0 million in 2024.